Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 19;9(5):103.
doi: 10.3390/jimaging9050103.

Tomosynthesis-Detected Architectural Distortions: Correlations between Imaging Characteristics and Histopathologic Outcomes

Affiliations

Tomosynthesis-Detected Architectural Distortions: Correlations between Imaging Characteristics and Histopathologic Outcomes

Giovanna Romanucci et al. J Imaging. .

Abstract

Objective: to determine the positive predictive value (PPV) of tomosynthesis (DBT)-detected architectural distortions (ADs) and evaluate correlations between AD's imaging characteristics and histopathologic outcomes.

Methods: biopsies performed between 2019 and 2021 on ADs were included. Images were interpreted by dedicated breast imaging radiologists. Pathologic results after DBT-vacuum assisted biopsy (DBT-VAB) and core needle biopsy were compared with AD detected by DBT, synthetic2D (synt2D) and ultrasound (US).

Results: US was performed to assess a correlation for ADs in all 123 cases and a US correlation was identified in 12/123 (9.7%) cases, which underwent US-guided core needle biopsy (CNB). The remaining 111/123 (90.2%) ADs were biopsied under DBT guidance. Among the 123 ADs included, 33/123 (26.8%) yielded malignant results. The overall PPV for malignancy was 30.1% (37/123). The imaging-specific PPV for malignancy was 19.2% (5/26) for DBT-only ADs, 28.2% (24/85) for ADs visible on DBT and synth2D mammography and 66.7% (8/12) for ADs with a US correlation with a statistically significant difference among the three groups (p = 0.01).

Conclusions: DBT-only ADs demonstrated a lower PPV of malignancy when compared with syntD mammography, and DBT detected ADs but not low enough to avoid biopsy. As the presence of a US correlate was found to be related with malignancy, it should increase the radiologist's level of suspicion, even when CNB returned a B3 result.

Keywords: B3 lesions; Breast Cancer Screening Program; DBT-vacuum assisted biopsy; architectural distortion; breast cancer; breast imaging; synthetic2D; tomosynthesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the study.
Figure 2
Figure 2
69 years old woman who presented for screening mammography with an AD of 25 mm, in left upper-external quadrant (circle). AD was fully appreciable on DBT images (a,b), on DBT spot compression (c) and on synt2D images (d,e). It showed US correlate (f), therefore US-CNB was performed. At histological analysis, a tubular carcinoma was found.

References

    1. Gaur S., Dialani V., Slanetz P.J., Eisenberg R.L. Architectural Distortion of the Breast. Am. J. Roentgenol. 2013;201:W662–W670. doi: 10.2214/AJR.12.10153. - DOI - PubMed
    1. D’Orsi C.J., Sickles E.A., Mendelson E.B., Morris E.A. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. American College of Radiology; Reston, VA, USA: 2013.
    1. Durand M.A., Wang S., Hooley R.J., Raghu M., Philpotts L.E. Tomosynthesis-detected Architectural Distortion: Management Algorithm with Radiologic-Pathologic Correlation. RadioGraphics. 2016;36:311–321. doi: 10.1148/rg.2016150093. - DOI - PubMed
    1. Bahl M., Baker J.A., Kinsey E.N., Ghate S.V. Architectural Distortion on Mammography: Correlation With Pathologic Outcomes and Predictors of Malignancy. Am. J. Roentgenol. 2015;205:1339–1345. doi: 10.2214/AJR.15.14628. - DOI - PubMed
    1. Babkina T.M., Gurando A.V., Kozarenko T.M., Gurando V.R., Telniy V.V., Pominchuk D.V. Detection of breast cancers represented as architectural distortion: A comparison of full-field digital mammography and digital breast tomosynthesis. Wiadomości Lek. 2021;74:1674–1679. doi: 10.36740/WLek202107121. - DOI - PubMed